ANIP
ANIP
US00182C1036
ANI Pharmaceuticals, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.7B EUR
1.9B EUR
1.76B EUR
1.78B EUR
Enterprise Value
1.79B EUR
2.15B EUR
2.06B EUR
2.11B EUR
Valuation Multiples
Trailing P/E
15.99x
17.56x
19.09x
28.34x
Forward P/E
7.11x
--
--
--
Price to Sales
1.73x
1.94x
1.9x
2.59x
Price to Book
2.65x
3.18x
3.13x
3.28x
EV/Revenue
1.83x
2.2x
2.23x
3.07x
EV/EBITDA
8.56x
10x
10.5x
15.34x
Price to FCF (P/FCF)
12.84x
11.35x
9.62x
13.08x
EV/FCF
13.55x
12.85x
11.28x
15.52x
FCF Yield
7.79%
8.81%
10.39%
7.65%
ende